Early outcomes with XIENCE™ Stent, implanted in complex patients, reveal excellent rates of definite stent thrombosis (ST) at 30 days:
With XIENCE™ Stent there is a 75% lower rate of acute (24-hour) definite ST compared to Synergy‡.5
With XIENCE™ Stent there is an 88% lower rate of early (30-day) definite ST compared to Resolute‡.6
XIENCE™ Stent has the most exceptional rates—and consistently the lowest rates—of late and very late ST.1 It’s another example of how XIENCE™ Stent delivers unparalleled patient outcomes which last far beyond the intervention.1
Even when examining ultra-long-term safety, XIENCE™ Stent reveals excellent patient outcomes—0.8% ST 10 years after PCI.12
MAT-2101793 v2.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0